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Supplementary Figure S3 . qPCR of candidate CNV regions that were called using a read depth based mapping software, CNVnator. (a) two somatic duplication candidates specific to PFC, (b) two somatic duplication candidates specific to cerebellum, and (c) two somatic deletion candidates specific to cerebellum. The cerebellum specific deletion in C3P1 was the only successful validation. Figure S5 . Full images of agarose gels from Figure 2 . NC1 molecular biology grade water was used for non-template negative PCR control. NC2, 1ul of non-template negative PCR product was used as a template for NC2. PFC: prefrontal cortex, Cere: cerebellum. DNA fragments which were sequenced are indicated by arrow. Supplementary Figure S10 . The number of somatic deletions (total 100) that we generated in the simulated whole genome sequencing data (blue) compared to the number of somatic deletions (total 78) that we detected (red) in the simulated data using our integrated pipeline. There were no false positives detected. breakpoints.
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Supplementary Figure S13 . Number of supporting reads of detected germline deletions and somatic deletions using Pindel in simulation experiment.
Supplementary Methods
Whole genome sequencing
For whole-genome sequencing (WGS), at least two DNA libraries were constructed to minimize the short-read redundancy of PCR duplicates, which could bias the read depth of sequencing coverage. DNA library preparation was carried out using Illumina, Inc., paired-end protocols. In brief, 1µg of genomic DNA isolation was fragmented to insert size between 200 to 700 bp using Covaris Acoustic Solubilizer (Covaris Inc.) with 20% duty cycle, 4 intensity, and 200 cycles per burst for 160 sec, at 4°C. These fragments were electrophoresed on a 2% agarose gel from where the 350-450 bp fraction was excised and extracted using the Qiagen gel extraction kit. The size-fractionated DNA was end repaired using T4 DNA polymerase, Klenow polymerase and T4 polynucleotide kinase. The resulting blunt-ended fragments were A-tailed using a 3′-5′ exonuclease-deficient Klenow fragment and ligated to Illumina paired-end adaptor oligonucleotides in a 'TA' ligation at room temperature for 15 min. The ligation mixture was electrophoresed on a 2% agarose gel and size-selected by removing a 2-mm horizontal slice of gel at ~500 bp using a sterile scalpel blade. DNA was extracted from the agarose as above. 10ng of the resulting DNA was PCR-amplified for 18 cycles using 2 units of Phusion polymerase. PCR cleanup was performed using AMPure beads (Agencourt BioSciences Corporation) following the manufacturer's protocol.
Paired-end read alignment
Paired-end reads were mapped to the hg18 human reference genome using 
Identifying germline deletion and duplication
In the first discovery phase, BreakDancer 4 and CNVnator 5 were used to identify germline deletions in our data. Only CNVnator 5 was used to call germline duplications. Minimum mapping quality of 35 and cutoff standard deviation of four were used to detect structural variations from BreakDancer. Candidate regions were determined to be germline if they met the following two criteria. First, if the candidate regions in PFC and cerebellum had a called deletion that overlapped more than 50% with one another. Second, the PFC candidate region also had to overlap more than 50% of the region called in the blood. CNVs in blood tissue were used as a baseline reference variation to call germline CNVs. To remove false positives due to the performance of each variant calling tool, we extracted the results from both tools that overlapped. The methodology for determining germline deletions was identical to that used to determine if candidates were germline duplications. Thus, a germline duplication was called if both duplications from prefrontal cortex and cerebellum overlapped more than 50% and if the PFC duplication also overlapped more than 50% of the duplication called from blood DNA.
In the second phase, we called germline CNVs in data from a single tissue without comparing data from multiple tissues. Basically if a CNV is present in more than 50% of the sequenced genomes, we assumed that the CNV is a germline variation. We determined germline deletion candidates as those called with both tools, BreakDancer and CNVnator and the deletion sequence overlapped at least 50%. As BreakDancer does not support a duplication calling function, only
CNVnator was used to identify germline duplications.
In the exploratory phase, we reported germline CNV candidates from CNVnator duplication and deletion calls for four additional PFC samples without additional processing.
Identifying brain-specific somatic deletion candidates in the first discovery phase
We set a conservative computational analysis pipeline to identify brain specific somatic deletions. A brain specific somatic deletion was first called, using
Breakdancer, if the deletion in one brain area did not overlap with a deletion in the other area or in blood at all. Then if, for example, a PFC specific somatic deletion was called and there were no overlapping deletions in cerebellum or blood at all, we would then filter out candidates that were initially called as deletions at the same genomic locus in the other tissues using Pindel 6 . We further filtered all false positive candidates that showed a clear decline in read depth in the other tissues by visual inspection using CNVnator viewer. For calling PFC and cerebellum common somatic deletions, we identified deletion candidates if both deletions in PFC and cerebellum overlapped more than 50% mutually and did not overlap more than 50% any deletions from the blood. We then filtered false positive candidates if a deletion overlap was called in blood using Pindel or a candidate deletion showed a clear decline in read depth in blood by using CNVnator viewer. We called 60 somatic deletions specific to PFC, 34 specific to cerebellum and 41 common to both PFC and cerebellum but absent in blood using the pipeline. We validated the brain specific somatic deletions in 3 genes. However, we were unable to validate 13 somatic deletion candidates. Among the false positives, 8 were germline deletions which were present in all tissues we tested and were detected in our initial PCRs. Therefore, to determine why the false discovery rate (FDR) was so high we conducted further analysis by performing a manual inspection of the chromosomal regions and read depth of the candidates to find the potential cause of these false positives. We found repetitive DNA sequences highly homologous to 500bp (1X library insert size) upstream of the left breakpoint and/or 500bp downstream of the right breakpoint of the deletion and were within 1X deletion size from deletion breakpoint of four of the false positive candidates. We developed a pipeline to filter out such repetitive sequences which are likely to contribute to false deletion calls in paired end mapping as well as background noise in read depth based mapping 7 . The size of 6 of the 8 candidates which were actually germline deletions rather than somatic as originally called were relatively small (<400 bp).
Thus, such small size candidates were not called as germline deletions in our initial analysis using the read depth based mapping software, CNVnator, and consequently this is a less reliable method for detecting small CNVs than paired end mapping 8 . We therefore filtered out relatively small size candidates (<400bp)
in our analysis pipeline to reduce the FDR. Furthermore, visual inspection was also performed to remove false positive candidates that showed a clear deletion pattern in read depth by using CNVnator with 200-bp windows but not called deletions by the software. The Blat filter and size filter were added to our somatic deletion calling pipeline for sequencing data from multiple tissues from the same individual to reduce false positive findings.
Identifying somatic deletion candidates in the second phase
Validating candidates identified in the first discovery phase would guarantee the presence of brain-specific somatic deletions. Thus, in the second phase, we searched for somatic deletion candidates in data obtained from the PFC of two schizophrenic cases and two unaffected control samples. If a germline deletion occurs, all the cells in the human body have the variation. For a homozygote germline deletion both alleles will have the variation whereas for a heretozygote germline deletion only one allele will have the variation. In contrast, somatic deletions which can occur in any stage of brain development, will only affect a fraction of brain cells. Thus, only a fraction of brain cells will have the somatic deletion and the deletion will be present in less genomic DNA extracted from the brain tissue than a heterozygote germline deletion that will be present in half of the genomic DNA. Consequently a somatic variation can be detected in WGS data from a single brain tissue by modifying the parameters of the individual programs used in our calling pipeline that we used in the first discovery phase of the study. 
Blat filtering
According to the characteristics of paired-end sequence data, misguided multiple mapping of paired reads occurring by sequence homology causes false positive variation detection. Previous approaches have used strict mapping quality or supporting read numbers to overcome these errors 7 . However, we predicted that somatic deletion candidate detection relied on detecting candidates with only a few supporting reads. To remove false positives without excluding such uncertain candidates, we utilized Blat alignment tool to find false positives that occurred by sequence homology. For each deletion candidate, we read a 100-bp sequence (a single read size) near the breakpoint and searched for homologous sequences.
We filtered out deletion candidates if homologous sequences larger than 90-bp were found located in one insert size from another breakpoint. Searching homologous sequences was performed by standalone Blat v.34x13, and the overall filtering process was implemented by JAVA.
Validating breakpoints of germline and somatic deletions by PCR and Sanger sequencing
We used amplified chromosomal DNA for validation of germline deletions and for initial validation of somatic deletions as limited amounts of DNA were available from the same batch of extractions. For whole genome amplification, we used 50ng
of input DNA using REPL-g whole genome amplification kit (Qiagen). Deleted DNA fragments from the 4 novel germline deletions were amplified by PCR using 25ng
of DNA as a template. The specific primers for each deletion were designed using round PCRs were done using 100ng of DNA as template. PCR reactions were performed with or without 1X Q solution (Qiagen). PCR conditions were the same as the conditions for germline deletions described above. Nested PCR was then done using 1µl of first round PCR product as a template. PCR conditions were the same as described above. If a deleted DNA fragment was visualized on agarose gel by nested PCR, the DNA fragments were sequenced after gel extraction (Qiagen). If a deleted DNA fragment was not visualized on agarose gel, nested PCR was re-performed using eluted DNA from first round PCR as a template. For extracting DNA fragments from agarose gel, first round PCR products were resolved by agarose gel electrophoresis. The agarose gel fragment was excised at the expected sizes of the deleted fragments and DNA was extracted using 
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